93 e-Letters

published between 2007 and 2010

  • NSAIDS and ESR in the onset of heart failure in rheumatoid arthritis
    David J Armstrong

    Dear Editor,

    Maradit-Kremers and colleagues raise several important issues in their excellent paper on heart failure in rheumatoid arthritis (RA) (1), but at least two important questions as well. Although, as they point out, there have been previous links suggested between ESR and heart failure (2) many other factors can interfere with ESR. C-reactive protein (CRP), a much 'cleaner' measure of inflammation, and is...

    Show More
  • Aspirin versus acetaminophen for pain control in patients with cardiovascular risk
    Michal R. Pijak

    Dear Editor,

    I read with great interest the recently published EULAR recommendations for the management of early arthritis.(1) However, I would like to add a few words of comment regarding the use of analgesicsin patients with cardiovascular (CV) and gastrointestinal (GI) risk factors. In my opinion the rational choice for such patients is the use ofaspirin combined with a proton-pump inhibitor.


    Show More
  • Tumour necrosis factor alpha antagonist-induced psoriasis: A mystery
    Jean-David Cohen

    Dear Editor,

    We read with interest the editorial of Ritchlin and Tausk1 about psoriasiform lesions developed in patients receiving tumour necrosis factor (TNF)α antagonists. We would like to provide additional information. Indeed, we have recently reported 6 cases of psoriasiform lesions during TNFα antagonist therapy and described common characteristics of this paradoxical reaction with 40 cases already pu...

    Show More